Dr. Praveen Adusumilli

Dr Praveen Adusumilli is a Senior Consultant Medical Oncologist with 18 years of clinical experience in medical oncology and paediatric haemato-oncology, specialising in immunotherapy, targeted therapy, stem cell transplantation, and the management of thoracic, gynaecological, breast, gastrointestinal, and haematological cancers.

 Dr Praveen is currently associated with CARE Hospital, Hitec City, Hyderabad.

Areas of Expertise

Dr Praveen Adusumilli specialises in medical oncology with strong expertise across immunotherapy, targeted therapy, stem cell transplantation, thoracic oncology, gynaecological oncology, breast oncology, gastrointestinal oncology, haemato-oncology, preventive oncology, and clinical trials.

Immunotherapy

He provides advanced immunotherapy-based treatment for patients with a range of solid tumours and haematological malignancies, delivering evidence-based immune-oncology protocols tailored to individual patient profiles to achieve effective tumour control and improved survival outcomes.

Targeted Therapy

Dr Praveen Adusumilli administers targeted therapy for patients with molecularly defined cancers including HER2-positive breast cancer, lung cancer with driver mutations, and other targetable malignancies, providing precision oncology treatments designed to maximise therapeutic benefit while minimising systemic toxicity.

Stem Cell Transplantation

He provides expertise in bone marrow transplantation and stem cell transplantation for patients with haematological malignancies and other conditions requiring transplant-based therapy, delivering structured pre-transplant evaluation, transplant management, and post-transplant care for optimal patient recovery.

Thoracic Oncology

Dr Praveen Adusumilli provides comprehensive medical oncology management for patients with lung and other thoracic cancers, offering individualised systemic treatment strategies including chemotherapy, targeted therapy, and immunotherapy for effective disease management and quality of life preservation.

Breast Oncology

He provides specialised medical oncology care for patients with breast cancer across all stages, delivering personalised treatment plans including chemotherapy, hormone therapy, targeted therapy, and immunotherapy to achieve the best possible oncological and functional outcomes.

Gastrointestinal Oncology

Dr Praveen Adusumilli manages patients with gastrointestinal cancers including stomach, pancreatic, liver, and colorectal malignancies, offering evidence-based systemic treatment protocols tailored to disease stage, molecular profile, and individual patient needs.

Gynaecological Oncology

He provides medical oncology management for patients with gynaecological cancers including ovarian, cervical, and endometrial malignancies, delivering comprehensive systemic treatment strategies focused on disease control, symptom management, and long-term patient wellbeing.

Haemato-Oncology

Dr Praveen Adusumilli provides specialised management for haematological malignancies including leukaemia, lymphoma, and myeloma, offering evidence-based treatment protocols including chemotherapy, targeted therapy, and stem cell transplantation for effective haematological cancer care.

Preventive Oncology

He provides preventive oncology consultations including cancer risk assessment, genetic counselling, screening recommendations, and lifestyle modification guidance, offering proactive and personalised strategies to reduce cancer risk and support early detection in high-risk individuals and families.

Clinical Trials

Dr Praveen Adusumilli actively participates in clinical trials, providing eligible patients access to novel and investigational cancer therapies, contributing to advancing oncological research and expanding treatment options for patients with complex and refractory malignancies.

Professional Experience

Current Affiliations

• Senior Consultant at CARE Hospital, Hitec City, Hyderabad

Previous Affiliations

• Senior Consultant at Medicover Hospital, Hitec City, Hyderabad
• Consultant at Apollo Cancer Centre, Hyderabad
• Consultant at HCG Cancer Centre, Visakhapatnam
• Consultant at Homi Bhabha Cancer Hospital and Research Centre, Visakhapatnam

Research and Publications

• Adusumilli P, Nayak L, Viswanath V, Digumarti L, Digumarti RR. Palliative Care and End-of-Life Measure Outcomes: Experience of a Tertiary Care Institute from South India. South Asian Journal of Cancer. 2018; 7(3): 210–213.
• Adusumilli P, Viswanath V, Digumarthi RR. A Prospective Study of the Usage of Pain Medication, Cost, Alternative Medication Use, and Outcome by Cancer Patients in Real World. Journal of the National Comprehensive Cancer Network. 2019; 17(3.5): HSR19-076.
• Adusumilli P, Konatam ML, Gundeti S, Bala S, Maddali LS. Treatment Challenges and Survival Analysis of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in Real World. Indian Journal of Medical and Paediatric Oncology. 2017; 38(1): 22–27.
• Danthala M, Gundeti S, Kuruva SP, Puligundla KC, Adusumilli P, Karnam AP, Bala S, Konatam ML, Maddali LS, Digumarti RR. Generic Imatinib in Chronic Myeloid Leukemia: Survival of the Cheapest. Clinical Lymphoma, Myeloma and Leukemia. 2017; 17(7): 457–462.

Credentials and Qualifications

Educational Background

• MBBS – Siddhartha Medical College, Vijayawada, Andhra Pradesh, 2008
• MD Medicine – Alluri Sitarama Raju Academy of Medical Sciences, Eluru, Andhra Pradesh, 2014
• DM Medical Oncology – Nizams Institute of Medical Sciences, Hyderabad, Telangana, 2017
• Training in BMT and Immunotherapy – Homi Bhabha Cancer Hospital and Research Centre, Visakhapatnam
• Telangana State Medical Council – Registration No. 60085, 2008

Memberships

• American Society of Clinical Oncology
• European Society for Medical Oncology
• Indian Society of Medical and Paediatric Oncology

Languages

• English
• Hindi
• Telugu

Book an Appointment with Dr Praveen Adusumilli, Medical Oncologist in Hyderabad

Connect via HexaHealth for seamless scheduling and priority consultation with Dr Praveen Adusumilli at CARE Hospital, Hitec City, Hyderabad.